A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Status:
Not yet recruiting
Trial end date:
2025-05-08
Target enrollment:
Participant gender:
Summary
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing,
perianal Crohn's disease and to assess the overall safety of guselkumab.